Boronic-Acid-Modified Nanomaterials for Biomedical Applications

Area of Science:

• Nanomaterials Science
• Biomedical Engineering
• Carbohydrate Chemistry

Background:

• Boronic-acid-modified nanomaterials offer biocompatibility and reversible binding to diols in biomolecules like saccharides and DNA.
• Variations in nanomaterial sources and synthesis impact their biomedical utility.
• Surface functionalization is key to enhancing nanomaterial performance in medicine.

Purpose of the Study:

• To review recent advancements in boronic-acid-modified nanomaterials, focusing on carbon dots (CDs) and graphene oxides.
• To highlight applications in bioimaging, biosensing, and antiviral inhibition.
• To explore future opportunities for nanomedicine in diagnostics and targeted treatment.

Main Methods:

• Literature review of studies on boronic-acid-modified carbon dots and graphene oxides.
• Analysis of applications in bioimaging, biosensing, and antiviral therapies.
• Focus on multivalent interactions for enhanced targeting.

Main Results:

• Boronic-acid-modified CDs and graphene oxides demonstrate significant potential in various biomedical fields.
• Multivalent interactions are identified as a crucial factor for improved therapeutic targeting.
• Synergistic opportunities exist for advanced nanomedicine applications.

Conclusions:

• Boronic-acid-modified nanomaterials, particularly CDs, are valuable tools for nanomedicine.
• Surface functionalization strategies are vital for optimizing their biomedical applications.
• Future research should leverage multivalent interactions for enhanced diagnostics and targeted therapies.